Open Rank Faculty - Instructor, Assistant, Associate or Full Professor - Pharmacoepidemiolgy
Rutgers Center for Pharmacoepidemiology and Treatment Science
Location: New Brunswick, New Jersey
Type: Full Time
Preferred Education: Doctorate
Academic / Research
College / University
Internal Number: 21FA1506
The Center for Pharmacoepidemiology and Treatment Science (PETS) at Rutgers, The State University of New Jersey invites applications for multiple faculty positions in Pharmacoepidemiology of all ranks.
We are seeking exceptional researchers at all career stages (Instructor, Assistant, Associate, or Full Professor) who are dedicated to developing or maintaining their own independent research programs, have a commitment to collaborative work and graduate teaching, and show the ability to be leaders in the field of pharmacoepidemiology. Successful candidates will have an established track record of publication and funding commensurate with their career stage. Candidates from non-academic or industry settings will have a track record of research productivity and a clear intent to pursue an independent, funded research program. PETS is committed to supporting researchers and teachers in pharmacoepidemiology who are dedicated to academic excellence and research that improves the health and wellness of individuals and populations.
In addition to their appointment at PETS, applicants will receive academic appointments at Rutgers University as relevant to their background, including but not limited to the Ernest Mario School of Pharmacy, Robert Wood Johnson Medical School, New Jersey Medical School, or the School of Public Health. The majority of the faculty’s effort will be dedicated to pharmacoepidemiology research and the PETS Center. The position is full-time, tenure-track or tenured, with a competitive start-up, full support for 3 years, and the expectation of having grant support, commensurate with their career stage, by the beginning of the 4th year on the PETS faculty.
Applicants may apply directly on our website:
The ideal candidate will have:
· A doctorate degree and doctorate-level training in pharmacoepidemiology, epidemiology, or related disciplines, or a clinical degree with Master’s level training in these fields.
· A research focus in the field of pharmacoepidemiology.
· A strong track record of peer-reviewed journal articles.
· Postdoctoral training; a K-award, R21 or R34 funding, and/or other evidence of preparation to become an R01-funded principal investigator; R01 or comparable funding (as appropriate for the candidate’s career stage). Additional Qualifications:
· Enthusiasm for contributing to and expanding an innovative program in pharmacoepidemiology research and training.
· Experience in teaching or mentoring in the field of pharmacoepidemiology or related disciplines.
· Excellent organization, planning, project management, and problem-solving skills.
· Essential ability to interact effectively and sustain relationships with investigators, colleagues, and partners at multiple locations.
· A demonstrated ability to provide leadership in one or more lines of research and to collaborate across multi-disciplinary teams.
About Rutgers Center for Pharmacoepidemiology and Treatment Science
The Center for Pharmacoepidemiology and Treatment Science (PETS) facilitates and performs innovative, multidisciplinary science related to the use and outcomes of therapeutics and diagnostics in large populations. The mission of the center is to advance pharmacoepidemiology and related fields by conducting world-class research and facilitating high-quality training. The nascent Center builds on strong existing faculty and research infrastructure and enjoys substantial support from Rutgers Biomedical and Health Science (RBHS). RBHS was created during the 2013 integration of the health professional schools from Rutgers University and the former University of Medicine and Dentistry of New Jersey. The eight schools, six centers and institutes and a behavioral health care network of RBHS collectively comprise one of America’s largest, most comprehensive university-based centers for studying and improving human health and health care.
The Institute for Health, RBHS, and the substantial resources of Rutgers University offer a rich collaborative environment for conducting pharmacoepidemiology and health services research. RBHS is home to Rutgers Health Group, New Jersey’s largest multi-...specialty medical group that includes the state’s only NCI-designated comprehensive cancer center, a large behavioral health delivery system, and Robert Wood Johnson Partners, a commercial and Medicare ACO. RBHS partners with RWJBarnabas Health, the state’s largest healthcare delivery system. Research among these units expands considerably the opportunities for researchers. The Institute for Health has faculty and other researchers with considerable expertise in pharmacoepidemiology the social and clinical sciences, health research and policy, public health, and related fields. Its faculty have exceptional capacity to address the most pressing health and healthcare challenges. Considerable strength exists in the analysis of large, integrated health-related clinical and administrative datasets, national surveys, and other data. Researchers within PETS and the Institute have great depth of expertise and experience in the analysis of Medicaid, Medicare, and private insurance data and the application of social science theory and advanced statistical techniques in large data sets.